7 May 2010 07:00
| For immediate release | 7 May 2010 |
ALLIANCE PHARMA PLC
("the Company")
Major Interest in Shares
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 6 May 2010 that Nigel Wray purchased, on 5 May 2010, 750,000 ordinary shares of 1p each in the Company.
Mr Wray's resultant shareholding is 25,269,995 ordinary shares, equivalent to 11.08% of the Company's issued share capital.
Mr Wray's ordinary shares are held as follows:
| Nominee | Number of ordinary shares |
|
Pershing Keen Nominees Limited Smith & Williamson Nominees Limited Roy Nominees Limited
|
9,405,407 50,000 15,814,588
|
For further information:
Alliance Pharma plc | + 44 (0) 1249 466966 |
| John Dawson, Chief Executive |
|
| Richard Wright, Finance Director |
|
| www.alliancepharma.co.uk |
|
|
|
|
Buchanan Communications | + 44 (0) 20 7466 5000 |
| Mark Court / Stasa Filiplic / Jennie Spivey |
|
|
|
|
| Numis Securities Limited | + 44 (0) 20 7260 1000 |
| Nominated Adviser: Michael Meade / Brent Nabbs |
|
| Corporate Broking: David Poutney |
|
Alliance Pharma (APH)